141 related articles for article (PubMed ID: 24445924)
1. Comparative analysis of drug action on B-cell proliferation and differentiation for mycophenolic acid, everolimus, and prednisolone.
Haneda M; Owaki M; Kuzuya T; Iwasaki K; Miwa Y; Kobayashi T
Transplantation; 2014 Feb; 97(4):405-12. PubMed ID: 24445924
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolic acid differentially impacts B cell function depending on the stage of differentiation.
Karnell JL; Karnell FG; Stephens GL; Rajan B; Morehouse C; Li Y; Swerdlow B; Wilson M; Goldbach-Mansky R; Groves C; Coyle AJ; Herbst R; Ettinger R
J Immunol; 2011 Oct; 187(7):3603-12. PubMed ID: 21873529
[TBL] [Abstract][Full Text] [Related]
3. Effects of sotrastaurin, mycophenolic acid and everolimus on human B-lymphocyte function and activation.
Matz M; Lehnert M; Lorkowski C; Fabritius K; Unterwalder N; Doueiri S; Weber UA; Mashreghi MF; Neumayer HH; Budde K
Transpl Int; 2012 Oct; 25(10):1106-16. PubMed ID: 22816666
[TBL] [Abstract][Full Text] [Related]
4. The influence of immunosuppressive drugs on neural stem/progenitor cell fate in vitro.
Skardelly M; Glien A; Groba C; Schlichting N; Kamprad M; Meixensberger J; Milosevic J
Exp Cell Res; 2013 Dec; 319(20):3170-81. PubMed ID: 24001738
[TBL] [Abstract][Full Text] [Related]
5. [The effect of mycophenolic acid on activation antigen expression and in vitro T lymphocytes proliferation in peripheral blood].
Zheng W; Huang H; Xu C
Zhonghua Nei Ke Za Zhi; 2002 May; 41(5):329-32. PubMed ID: 12133428
[TBL] [Abstract][Full Text] [Related]
6. Chronopharmacokinetics of mycophenolic acid and its glucuronide and acyl glucuronide metabolites in kidney transplant recipients converted from cyclosporine to everolimus.
Tedesco-Silva H; Felipe CR; Slade A; Schmouder RL; Medina Pestana JO
Ther Drug Monit; 2012 Dec; 34(6):652-9. PubMed ID: 23131696
[TBL] [Abstract][Full Text] [Related]
7. Everolimus-treated renal transplant recipients have a more robust CMV-specific CD8+ T-cell response compared with cyclosporine- or mycophenolate-treated patients.
Havenith SH; Yong SL; van Donselaar-van der Pant KA; van Lier RA; ten Berge IJ; Bemelman FJ
Transplantation; 2013 Jan; 95(1):184-91. PubMed ID: 23222818
[TBL] [Abstract][Full Text] [Related]
8. Substantial proliferation of human renal tubular epithelial cell-reactive CD4+CD28null memory T cells, which is resistant to tacrolimus and everolimus.
Demmers MW; Baan CC; Janssen M; Litjens NH; Ijzermans JN; Betjes MG; Weimar W; Rowshani AT
Transplantation; 2014 Jan; 97(1):47-55. PubMed ID: 24157471
[TBL] [Abstract][Full Text] [Related]
9. Combined standard and novel immunosuppressive substances affect B-lymphocyte function.
Matz M; Lehnert M; Lorkowski C; Fabritius K; Weber UA; Mashreghi MF; Neumayer HH; Budde K
Int Immunopharmacol; 2013 Apr; 15(4):718-25. PubMed ID: 23499640
[TBL] [Abstract][Full Text] [Related]
10.
Krueger MB; Bonifacius A; Dragon AC; Santamorena MM; Nashan B; Taubert R; Kalinke U; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
Transpl Int; 2024; 37():12720. PubMed ID: 38655204
[TBL] [Abstract][Full Text] [Related]
11. Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B Cells.
Traitanon O; Mathew JM; La Monica G; Xu L; Mas V; Gallon L
PLoS One; 2015; 10(6):e0129658. PubMed ID: 26087255
[TBL] [Abstract][Full Text] [Related]
12. Maintenance immunosuppressive therapy with everolimus preserves humoral immune responses.
Struijk GH; Minnee RC; Koch SD; Zwinderman AH; van Donselaar-van der Pant KA; Idu MM; ten Berge IJ; Bemelman FJ
Kidney Int; 2010 Nov; 78(9):934-40. PubMed ID: 20703211
[TBL] [Abstract][Full Text] [Related]
13. Effect of mycophenolic acid and bortezomib on purified human B cells: an in vitro study of long-term functionally stable MICA-sensitized renal recipients.
Li Zw; Wen Xf; Wang Y; Luo M; Qiu Jx
Exp Clin Transplant; 2013 Dec; 11(6):482-8. PubMed ID: 23745955
[TBL] [Abstract][Full Text] [Related]
14. Responsiveness of preactivated B cells to IL-2 and IL-6. Effect of cyclosporine and rapamycin.
Hornung N; Raskova J; Raska K; Degiannis D
Transplantation; 1993 Oct; 56(4):985-90. PubMed ID: 7692641
[TBL] [Abstract][Full Text] [Related]
15. Effects of immunosuppressive drugs on purified human B cells: evidence supporting the use of MMF and rapamycin.
Heidt S; Roelen DL; Eijsink C; van Kooten C; Claas FH; Mulder A
Transplantation; 2008 Nov; 86(9):1292-300. PubMed ID: 19005412
[TBL] [Abstract][Full Text] [Related]
16. Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help.
Heidt S; Roelen DL; Eijsink C; Eikmans M; van Kooten C; Claas FH; Mulder A
Clin Exp Immunol; 2010 Feb; 159(2):199-207. PubMed ID: 19922499
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte suppression by glucocorticoids with cyclosporine, tacrolimus, pentoxifylline, and mycophenolic acid.
Briggs WA; Eustace J; Gimenez LF; Choi MJ; Scheel PJ; Burdick JF
J Clin Pharmacol; 1999 Feb; 39(2):125-30. PubMed ID: 11563403
[TBL] [Abstract][Full Text] [Related]
18. An optimized assay for the enumeration of antigen-specific memory B cells in different compartments of the human body.
Cao Y; Gordic M; Kobold S; Lajmi N; Meyer S; Bartels K; Hildebrandt Y; Luetkens T; Ihloff AS; Kröger N; Bokemeyer C; Atanackovic D
J Immunol Methods; 2010 Jun; 358(1-2):56-65. PubMed ID: 20302874
[TBL] [Abstract][Full Text] [Related]
19. In vitro effects of everolimus and intravenous immunoglobulin on cell proliferation and apoptosis induction in the mixed lymphocyte reaction.
Amet N; Gacad M; Petrosyan A; Pao A; Jordan SC; Toyoda M
Transpl Immunol; 2010 Aug; 23(4):170-3. PubMed ID: 20609387
[TBL] [Abstract][Full Text] [Related]
20. Effect of everolimus-based drug regimens on CMV-specific T-cell functionality after renal transplantation: 12-month ATHENA subcohort-study results.
Hauser IA; Marx S; Sommerer C; Suwelack B; Dragun D; Witzke O; Lehner F; Schiedel C; Porstner M; Thaiss F; Neudörfl C; Falk CS; Nashan B; Sester M
Eur J Immunol; 2021 Apr; 51(4):943-955. PubMed ID: 33306229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]